Description
In This Episode:
- Nicole Gormley, Director, Division of Hematologic Malignancies II, FDA
- B. Amore, Trial Participant on AMY3001 Clinical Trial
- Raymond Comenzo, Director of Transfusion Services, Tufts University School of Medicine
- Bindu Kanapuru, Medical Officer, Division of Hematologic Malignancies II, FDA
- Jessica Vermeulen, Vice President, Clinical Research and Development, Janssen
| Name | Financial Relationships | Disclosure Type | Role |
| N. Gormley | No Relationships | Speaker | |
| B. Amore | No Relationships | Speaker | |
| R. Comenzo | Janssen; Takeda | Grants/Research Support | Speaker |
| B. Kanapuru | No Relationships | Speaker | |
| J. Vermeulen | Janssen | Full-time/part-time Employee | Speaker |
FDA staff involved in the development and review of this activity have disclosed no relevant financial relationships.
AACR staff involved in the development and review of this activity have disclosed no relevant financial relationships.
Questions About CE?
Please contact the Office of CME at (215) 440-9300 or cme@aacr.org.
DARA SC + CyBorD PRESCRIBING INFORMATION